Literature DB >> 18074353

Familial clustering of cancer at human papillomavirus-associated sites according to the Swedish Family-Cancer Database.

Shehnaz K Hussain1, Jan Sundquist, Kari Hemminki.   

Abstract

Familial aggregation of cervical cancer has been demonstrated previously, however aggregation of other human papillomavirus-associated anogenital, upper aerodigestive tract and skin cancers has not been fully characterized. The Swedish Family-Cancer Database, which contains reliable data on cancer incidence and nuclear family linkages for all residents of Sweden between 1958 and 2004, was used to calculate standardized incidence ratios (SIR) and 95% confidence intervals for offspring site-specific cancer risks according to site-specific cancer in sibling and parental probands. Offspring cancer risk was significantly increased when either a sibling or parent was affected at the same site for penile squamous cell carcinoma (SCC, SIR = 7.54), cervical adenocarcinoma (AC, SIR = 2.31), vulvar SCC (SIR = 2.27), skin SCC (SIR = 2.14), rectal AC (SIR = 1.86), in situ cervical SCC (SIR = 1.80), invasive cervical SCC (SIR = 1.77) and upper aerodigestive tract SCC (SIR = 1.57). Significant aggregation on the order of 2-fold between anogenital cancers at different sites or histologies was also observed. In situ cervical SCC risk in offspring was strongly influenced by siblings affected with oropharyngeal SCC (SIR = 3.17) and tonsillar SCC (SIR = 1.84). Familial skin SCC was largely unassociated with anogenital or upper aerodigestive tract cancer risk in offspring. These data suggest that common host factors exist among individuals affected with anogenital and upper aerodigestive tract cancers.

Entities:  

Mesh:

Year:  2008        PMID: 18074353     DOI: 10.1002/ijc.23265

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment.

Authors:  Kari Hemminki; Anna Kanerva; Asta Försti; Akseli Hemminki
Journal:  BMC Cancer       Date:  2022-04-26       Impact factor: 4.638

2.  Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer.

Authors:  Mahboobeh Safaeian; Allan Hildesheim; Paula Gonzalez; Kai Yu; Carolina Porras; Qizhai Li; Ana Cecilia Rodriguez; Mark E Sherman; Mark Schiffman; Sholom Wacholder; Robert Burk; Rolando Herrero; Laurie Burdette; Stephen J Chanock; Sophia S Wang
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

3.  Comparison of Familial Clustering of Anogenital and Skin Cancers Between In Situ and Invasive Types.

Authors:  Luyao Zhang; Otto Hemminki; Guoqiao Zheng; Asta Försti; Kristina Sundquist; Jan Sundquist; Kari Hemminki
Journal:  Sci Rep       Date:  2019-11-06       Impact factor: 4.379

Review 4.  A Comprehensive Discussion in Vaginal Cancer Based on Mechanisms, Treatments, Risk Factors and Prevention.

Authors:  Sumit Kumar Baral; Partha Biswas; Md Abu Kaium; Md Aminul Islam; Dipta Dey; Md Al Saber; Tanjim Ishraq Rahaman; A M; Talha Bin Emran; Md Nazmul Hasan; Mi-Kyung Jeong; Ihn Han; Md Ataur Rahman; Bonglee Kim
Journal:  Front Oncol       Date:  2022-07-18       Impact factor: 5.738

5.  Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma.

Authors:  Mahboobeh Safaeian; Lisa G Johnson; Kai Yu; Sophia S Wang; Patti E Gravitt; John A Hansen; Mary Carrington; Stephen M Schwartz; Xiaojiang Gao; Allan Hildesheim; Margaret M Madeleine
Journal:  Front Oncol       Date:  2014-06-19       Impact factor: 6.244

Review 6.  New Insights into the Epidemiology of Vulvar Cancer: Systematic Literature Review for an Update of Incidence and Risk Factors.

Authors:  Lauro Bucchi; Margherita Pizzato; Stefano Rosso; Stefano Ferretti
Journal:  Cancers (Basel)       Date:  2022-01-13       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.